Medicare Enrolled

Dr. Asela Wickremasinghe, M.D.

Internal Medicine · Hanford, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
808 VAUGHN ST, Hanford, CA 93230
5594108404
In practice since 2006 (19 years)
NPI: 1164476081 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wickremasinghe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wickremasinghe? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wickremasinghe

Dr. Asela Wickremasinghe is an internal medicine specialist in Hanford, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Wickremasinghe performed 2,443 Medicare services across 1,185 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wickremasinghe received a total of $13,116 from 51 pharmaceutical and/or device companies across 848 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wickremasinghe is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 13% volume in CA $13,116 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,443
Medicare services
Top 13% in CA for internal medicine
1,185
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~129 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,197 $92 $158
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
351 $68 $108
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
272 $96 $220
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
261 $69 $200
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
233 $135 $200
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
42 $103 $239
Transitional care management, high complexity
Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem.
33 $231 $290
Ear wax removal by washing
This procedure involves the removal of impacted ear wax using a washing technique.
22 $12 $40
Transitional care management services, moderate complexity
Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity.
18 $171 $220
Annual wellness visit, initial visit
A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment.
14 $172 $230
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,116
Total received (2018-2024)
Avg $1,874/year across 7 years
Top 8% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
848
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,116 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,493
2023
$1,299
2022
$1,491
2021
$2,184
2020
$1,793
2019
$2,191
2018
$2,665

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$327
Boehringer Ingelheim Pharmaceuticals, Inc.
$224
Amgen Inc.
$187
Astellas Pharma US Inc
$144
Mylan Specialty L.P.
$133
Novo Nordisk Inc
$103
Bayer Healthcare Pharmaceuticals Inc.
$65
ABBVIE INC.
$57
Otsuka America Pharmaceutical, Inc.
$50
IRONWOOD PHARMACEUTICALS, INC
$49
PFIZER INC.
$36
Ardelyx, Inc.
$35
GlaxoSmithKline, LLC.
$30
Lilly USA, LLC
$25
Abbott Laboratories
$15
Merck Sharp & Dohme LLC
$13
Top 3 companies account for 49.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,398
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,039
Novo Nordisk Inc
$1,003
Amgen Inc.
$908
Merck Sharp & Dohme Corporation
$589
Janssen Pharmaceuticals, Inc
$549
AbbVie Inc.
$537
Lilly USA, LLC
$535
Amarin Pharma Inc.
$512
Mylan Specialty L.P.
$472
SANOFI-AVENTIS U.S. LLC
$430
GlaxoSmithKline, LLC.
$383
Astellas Pharma US Inc
$356
PFIZER INC.
$311
Ironwood Pharmaceuticals, Inc
$306
Allergan Inc.
$252
Biohaven Pharmaceutical Holding Company Ltd.
$214
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$212
Takeda Pharmaceuticals U.S.A., Inc.
$177
ABBVIE INC.
$175
Edwards Lifesciences Corporation
$131
Otsuka America Pharmaceutical, Inc.
$129
IRONWOOD PHARMACEUTICALS, INC
$128
Novartis Pharmaceuticals Corporation
$122
Biohaven Pharmaceuticals, Inc.
$115
Daiichi Sankyo Inc.
$112
Allergan, Inc.
$111
Abbott Laboratories
$103
Eisai Inc.
$84
Avanir Pharmaceuticals, Inc.
$71
Bayer Healthcare Pharmaceuticals Inc.
$65
Dexcom, Inc.
$64
Synergy Pharmaceuticals Inc
$57
Bayer HealthCare Pharmaceuticals Inc.
$57
IDORSIA PHARMACEUTICALS US INC
$41
Ardelyx, Inc.
$35
Medtronic, Inc.
$35
E.R. Squibb & Sons, L.L.C.
$33
MannKind Corporation
$31
Mannkind Corporation
$30
Merck Sharp & Dohme LLC
$28
Kowa Pharmaceuticals America, Inc.
$26
UROVANT SCIENCES INC
$21
Alexion Pharmaceuticals, Inc.
$18
ARBOR PHARMACEUTICALS, INC.
$18
Horizon Therapeutics plc
$17
Shire North American Group Inc
$17
Ultragenyx Pharmaceutical Inc.
$16
EISAI INC.
$16
DEXCOM, INC.
$15
Sumitomo Pharma America, Inc.
$13
Top 3 companies account for 33.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · ANORO · Aimovig · BAQSIMI · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · CHANTIX · COMIRNATY · CREON · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · GEMTESA · Horizant · IBSRELA · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · KYPHON EXPRESS II KYPHOPAK TRAY · Kerendia · LEQVIO · LINZESS · LOKELMA · Linzess · Livalo · MOUNJARO · MYRBETRIQ · Motegrity · NATPARA (PARATHYROID HORMONE) · NUEDEXTA · NURTEC ODT · Otezla · Ozempic · PAXLOVID · PRALUENT · PREVNAR 20 · Perforomist · Prolia · QULIPTA · QUVIVIQ · RELISTOR ORAL · REXULTI · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Strensiq · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · Tresiba · Trintellix · Trulance · UBRELVY · VERQUVO · VESICARE · VIBERZI · VIIBRYD · VRAYLAR · Vascepa · Veozah · Victoza · XARELTO · XIFAXAN · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for internal medicine in CA.

Looking for an internal medicine specialist in Hanford?
Compare internal medicine physicians in the Hanford area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
117
Per 100K population
76.6
County median income
$68,750
Nearest hospital
ADVENTIST HEALTH HANFORD
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wickremasinghe is a clinical cardiology specialist, with above-average Medicare volume (top 13% in CA), with low-engagement industry engagement in the top 8% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wickremasinghe experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Wickremasinghe performed 1,197 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wickremasinghe receive payments from pharmaceutical companies?
Yes. Dr. Wickremasinghe received a total of $13,116 from 51 companies across 848 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wickremasinghe's costs compare to other internal medicine physicians in Hanford?
Dr. Wickremasinghe's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wickremasinghe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →